Skip to content
Screener

Bio-Techne TECH Dividends Paid

Dividends Paid at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
-$499M-408%
Danaher logo
DanaherDHR
$283M+23.6%
Bruker logo
BrukerBRKR
$7.5M-1.3%
Revvity logo
RevvityRVTY
$7.84M-7.0%
Agilent Technologies logo
Agilent TechnologiesA
$72M+2.9%

Other financials

Income statement

See full
Revenue$311.4M-1.5%
Gross profit$208.3M-2.9%
Operating income$75.5M+95.0%
Net income$51.0M+126%
EPS (diluted)$0.32+129%

Balance sheet

See full
Cash & equivalents$209.8M+49.2%
Total debt$290.3M-31.4%
Total equity$2.1B+3.3%
Total assets$2.6B-3.5%

Cash flow

See full
Operating cash flow$86.7M+111%
CapEx$9.1M-10.2%
Free cash flow$77.6M+150%

Valuation

See full
Market cap$11.22B+43.5%
Enterprise value$11.3B+39.5%
P/E74.9×+16.9×
P/S9.3×+2.9×

Profitability

See full
Gross margin65%-0.8pp
Operating margin14.2%-7.9pp
Net margin10.9%-6.7pp
FCF margin22.3%+4.0pp

Returns & leverage

See full
Return on equity6.5%-3.9pp
Debt / equity0.1×-0.1×
Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfDividendsCommonStock.

The source filing: Bio-Techne’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 4:31 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-056302
Line itemNine Months Ended / March 31, 2026Nine Months Ended / March 31, 2025
Proceeds from sale of assets held-for-sale4,6171,789
Net cash provided by (used in) investing activities(11,133)(35,589)
CASH FLOWS FROM FINANCING ACTIVITIES:
Cash dividends(37,432)(38,004)
Proceeds from stock option exercises58,19345,513
Repurchases of common stock(24)(175,674)
Borrowings under line-of-credit agreement38,000
Repayments of long-term debt(146,000)(27,000)

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Bio-Techne's dividends paid?
Bio-Techne (TECH) reported dividends paid of $12.52M in Q1 2026.
How has Bio-Techne's dividends paid changed year-over-year?
Bio-Techne's dividends paid decreased by 0.5% year-over-year, from $12.58M to $12.52M.
What is the long-term trend for Bio-Techne's dividends paid?
Over 3 years (2022 to 2025), Bio-Techne's dividends paid has grown at a 0.1% compound annual growth rate (CAGR), from $50.19M to $50.39M.
What does dividends paid mean?
Total cash dividends paid to common stockholders, reflecting the company's capital return policy.

Ask your AI about Bio-Techne's dividends paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude